Abstract |
Oxybutynin has been used for the management of detrusor overactivity for over 30 years and has withstood medical scrutiny and the test of time throughout the world. Although several agents in the class of bladder relaxants have only recently been studied, oxybutynin's effectiveness in reducing urinary frequency and urge urinary incontinence is unquestioned in the medical literature. Oxybutynin is extremely safe and effective in almost every population including children, the elderly, and those who have neurogenic bladder. With more preparations available and more dosing flexibility than any other anticholinergic medication on the market, oxybutynin remains the "gold standard" for first-line therapy for patients who have detrusor overactivity.
|
Authors | Ananias Diokno, Michael Ingber |
Journal | The Urologic clinics of North America
(Urol Clin North Am)
Vol. 33
Issue 4
Pg. 439-45, vii
(Nov 2006)
ISSN: 0094-0143 [Print] United States |
PMID | 17011379
(Publication Type: Journal Article, Review)
|
Chemical References |
- Mandelic Acids
- Muscarinic Antagonists
- oxybutynin
|
Topics |
- Humans
- Mandelic Acids
(therapeutic use)
- Muscarinic Antagonists
(therapeutic use)
- Urinary Bladder, Overactive
(drug therapy)
|